Literature DB >> 32385805

Involvement of Histamine 2 Receptor in Alpha 1 Adrenoceptor Mediated Cardiac Hypertrophy and Oxidative Stress in H9c2 Cardio Myoblasts.

Ajay Godwin Potnuri1, Lingesh Allakonda2, Sherin Saheera3.   

Abstract

Despite the involvement of ɑ1adrenergic (ɑ1AR) and Histamine 2 receptors (H2R) in cardiac hypertrophy (CH), their relationship is yet to be studied. Our study investigated interrelationship between them using in vitro CH model. H9c2 cardiomyoblasts were exposed to phenylephrine (ɑ1AR agonist-50 μM) in the presence, the absence of famotidine (H2R antagonist-10 μM) and BAY 11-7082 (NF-kB inhibitor-10 μM). The impact of ɑ1AR stimulation on H2R expression and oxidative stress was assessed. Hypertrophic indices were assessed from activities of enzymatic mediators of cardiac hypertrophy, total protein content, BNP levels and cell volume. Additionally, the inverse agonistic property of famotidine and NFkB activity was also studied. ɑ1AR-induced H2R expression, oxidative stress and hypertrophic indices were significantly abolished by famotidine and pharmacological inhibitor of NFkB. Increase in constitutive activity of H2R was noticed correlating with increased receptor population. These results suggest involvement of NFkB-mediated upregulation of H2R in ɑ1AR-mediated CH.

Entities:  

Keywords:  Alpha 1 adrenergic receptor; Cardiac hypertrophy; Famotidine; Histamine 2 receptor; Phenylephrine

Year:  2020        PMID: 32385805     DOI: 10.1007/s12265-020-09967-6

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  26 in total

1.  β₂-Adrenoceptors, NADPH oxidase, ROS and p38 MAPK: another 'radical' road to heart failure?

Authors:  Fabio Di Lisa; Nina Kaludercic; Nazareno Paolocci
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

2.  Induction of the skeletal alpha-actin gene in alpha 1-adrenoceptor-mediated hypertrophy of rat cardiac myocytes.

Authors:  N H Bishopric; P C Simpson; C P Ordahl
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

Review 3.  Role of oxidative stress in cardiac hypertrophy and remodeling.

Authors:  Eiki Takimoto; David A Kass
Journal:  Hypertension       Date:  2006-12-26       Impact factor: 10.190

4.  Modeling hypertrophic IP3 transients in the cardiac myocyte.

Authors:  Michael Cooling; Peter Hunter; Edmund J Crampin
Journal:  Biophys J       Date:  2007-08-10       Impact factor: 4.033

5.  Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy.

Authors:  H W Lim; L J De Windt; L Steinberg; T Taigen; S A Witt; T R Kimball; J D Molkentin
Journal:  Circulation       Date:  2000-05-23       Impact factor: 29.690

6.  Alpha 1-adrenergic receptor stimulation of sarcomeric actin isogene transcription in hypertrophy of cultured rat heart muscle cells.

Authors:  C S Long; C P Ordahl; P C Simpson
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

Review 7.  Oxidative stress and redox signalling in cardiac hypertrophy and heart failure.

Authors:  Mike Seddon; Yee H Looi; Ajay M Shah
Journal:  Heart       Date:  2006-05-02       Impact factor: 5.994

8.  Myocardial oxidative stress contributes to transgenic β₂-adrenoceptor activation-induced cardiomyopathy and heart failure.

Authors:  Q Xu; A Dalic; L Fang; H Kiriazis; R H Ritchie; K Sim; X-M Gao; G Drummond; M Sarwar; Y-Y Zhang; A M Dart; X-J Du
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

9.  Alpha 1-adrenergic stimulation is coupled to cardiac myocyte hypertrophy.

Authors:  U Ikeda; Y Tsuruya; T Yaginuma
Journal:  Am J Physiol       Date:  1991-03

Review 10.  The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.

Authors:  Filippos Triposkiadis; George Karayannis; Grigorios Giamouzis; John Skoularigis; George Louridas; Javed Butler
Journal:  J Am Coll Cardiol       Date:  2009-11-03       Impact factor: 24.094

View more
  1 in total

1.  Famotidine promotes inflammation by triggering cell pyroptosis in gastric cancer cells.

Authors:  Jin Huang; Pingsheng Fan; Miao Liu; Chengtao Weng; Gaofei Fan; Tengyue Zhang; Xiaohong Duan; Yang Wu; Lili Tang; Guohong Yang; Yabei Liu
Journal:  BMC Pharmacol Toxicol       Date:  2021-10-22       Impact factor: 2.483

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.